Sentiment Trading

Krystal Biotech Inc’s first-quarter earnings fell short of expectations, but the company’s strategic global expansion efforts are expected to position it as a leader in the biotechnology sector and drive long-term growth.

Krystal Biotech, a biopharmaceutical company, will participate in upcoming scientific conferences to showcase its gene therapy platform for treating rare debilitating disorders.